CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Robert Califf

Former FDA Commissioner; Vice Chancellor for Health Data Science, Duke University

Search every verified Robert Califf interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Robert Califf, former FDA commissioner and current Duke University vice chancellor for health data science, appeared on three podcasts between August and October 2026. On The Life Science Rundown in October, he discussed GLP-1 therapies, stating that their potential as a public health success depends on affordability, equitable access, trustworthy information, and responsible regulation. He described the current pharmaceutical pricing system as rewarding companies that charge high prices for drugs used by a narrow population, and he characterized the development of costly drugs to reverse diet-related obesity as "insane," while also expressing optimism about the class's potential. On the Duke Clinical Research Institute's podcast in September, Califf reflected on the institute's 30-year history and said that the biggest issue in U.S. clinical research is "fear of China," which he described as more organized in biotechnology and clinical trial networks compared to a "ragtag disaggregated" U.S. effort. In an August interview on Cutting to the Case, Califf discussed the future of medicine, emphasizing the growing role of artificial intelligence in aggregating clinical data and supporting real-time learning, while noting that doctors should be armed with high-quality evidence. He also commented on FDA policy, saying he agrees the agency should not make pharmaceutical cost decisions but that government bodies like CMS should evaluate costs and willingness to pay. Califf repeated his view that the field should rely more on randomized controlled trials rather than less, while also leveraging electronic health records, wearables, and other digital data sources.

Recent appearances

Notable quotes

“I really think we got a system right now which highly rewards pharmaceutical innovator companies for finding new drugs, and I think that's great. We need to reward them. But, the rewards are very high for those that can find a drug for which you can charge a lot of money to a narrow slice of the population. And this is a big change in the really in the way the pharmaceutical industry has been financially rewarded ove”

“If I were cynical, which of course I'm not, I would say, you know, if you dropped down from Mars and looked at the human condition, you would say, 'Why on earth did these people create an environment for food which led to a tremendous increase in overweight and obesity that could have been prevented had we just produced and eaten a good diet. And then we invent a drug that costs a fortune in order to reverse the effe”

“The biggest thing happening right now in the United States clinical research is fear of China. We're literally China has concluded as a society that biotechnology and medical therapeutics are right up there as one of the top three priorities. So they are completely organized from designing molecules all the way through phase one and now these enormous phase three clinical trial networks that they're putting together.”

“I agree with the American principle that the FDA should not be involved in cost decisions for pharmaceuticals, but I do think the government should be. The concept that you evaluate the risks and benefits based on the science is really core to the FDA, not being a political organization, but being a science organization. But if the benefits outweigh the risks, what it costs and what people are willing to pay for it i”

“China some time ago decided to get its act together and made biotechnology one of the nation's top priorities just like they did energy. I mean it's quite remarkable that when the straits of Hormuz were closed, China didn't even blink because it had already shifted to being the lead world's leading producer of solar and wind energy and it had developed very conservative approaches to oil. And I think in a similar fas”

“I think it is useful to take a step back and start out with your philosophical perspective. If you believe that there is value in having a civil service that provides continuity and standards and methods of doing things that are independent of politics, then I think you'd have to believe that we're undergoing a very dangerous time right now. If you believe that having those things is detrimental to the country, then ”

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →